Trump's 10% Credit Card Interest Cap Plan
Former US President Donald Trump pledges to cap credit card interest rates at 10% if re-elected, a move aimed at easing financial burdens on American families. Read the full analysis.
Former US President Donald Trump pledges to cap credit card interest rates at 10% if re-elected, a move aimed at easing financial burdens on American families. Read the full analysis.
The US dollar holds near a one-month high as investors await December jobs data and a crucial Supreme Court ruling on Trump-era tariffs. The outcomes could define the greenback's trajectory. Read more for expert analysis.
Explore the deep connection between astrology and astronomy through the eyes of famed astrologer William Lilly. Understand his famous quote and its relevance today. Read more for a unique perspective.
Groww Mutual Fund launches Groww Small Cap Fund NFO from Jan 8-22, 2026. Minimum investment ₹500. Aiming for long-term capital appreciation in high-potential small-cap stocks. Know key details.
A Russian oil tanker, the NS Century, sanctioned by the US, was tracked sailing in the English Channel. This comes just a day after the US seized another tanker for violating the G7 price cap. Read the full report.
US Rep. Eli Crane introduces bill to award Nick Shirley a Congressional Gold Medal for exposing alleged Minnesota daycare fraud. The viral video case now involves the FBI. Read the full story.
Singapore will host the Space Summit 2026, uniting global leaders to shape the future of the trillion-dollar space economy. Discover the key themes and goals.
Indian rupee strengthened against the US dollar, gaining 26 paise to reach 89.92 in early trade. The rise is attributed to a weaker dollar index and falling crude oil prices. Read the full analysis.
Nearly 60% of stocks saw weaker returns in 2025 vs 2024. Will 2026 bring another flip? Experts reveal the key factors for sustained outperformance. Read more.
Discover the fascinating journey of the humble monkey cap from Crimean War battlefields to Indian streets. Learn why this unassuming winter essential has survived decades of fashion trends.
Novo Nordisk launches oral Wegovy weight-loss drug in the US, priced at $299. The pill, approved in Dec 2025, aims to regain market share from rival Eli Lilly. UK approval expected end-2026.
Index data proves mid and small-cap funds consistently outperform large caps over the long term. Learn why they are essential for a diversified portfolio. Read the analysis.
Indian equity markets surged last week, adding Rs 1.24 lakh crore to the value of seven top firms. Reliance Industries led the rally, while IT majors faced pressure. Read the full analysis.
Ant-Man star Evangeline Lilly discloses traumatic brain injury results, revealing decreased brain function. Read her emotional update and road to recovery.
Marvel star Evangeline Lilly reveals traumatic brain injury diagnosis after a 2025 fall. Get the full health update and her recovery journey here.
Marvel star Evangeline Lilly shares a traumatic brain injury diagnosis after a 2025 accident in Hawaii. She details her recovery journey and life reassessment. Read her full story.
As 2026 begins, financial experts share diverse views on inflation, markets, and currency. Discover why discipline beats prediction and explore key insights on mutual funds, child education funding, and insurance reforms. Plan your money goals now.
The Indian rupee closed at 90.20 per dollar, marking a two-week low. Key factors include importer demand and RBI's intervention stance. Get the full market analysis here.
The US dollar starts 2026 stronger as markets await crucial US jobs data and President Trump's Fed chair nominee. The yen remains weak despite BOJ hikes. Key insights for investors.
The Indian rupee closed 2025 with a 4.72% annual decline, its worst performance since 2022. It began 2026 weaker due to corporate dollar demand. Read the full analysis.
India's small-cap mutual funds underperformed in 2025, with only one fund in the green. Discover the top long-term performers and why bank FDs remain a safe anchor for portfolios.
Novo Nordisk and Eli Lilly to launch oral GLP-1 drugs in 2026. Despite Novo's head start, analysts predict Lilly's market leadership in obesity and diabetes treatments will persist for years. Explore the details.
Australian and New Zealand dollars post solid 2025 gains vs USD. Hot inflation sparks RBA rate hike speculation for February. Key CPI data due next week will be crucial. Read more.
Emkay Global forecasts Nifty 50 at 29,000 in 12 months, offering double-digit returns. Mid & small-caps set to outperform with selective stock-picking. Read the full analysis.
Planning for a goal 5-7 years away? Experts reveal the ideal mix of large-cap, flexi-cap funds, debt, and gold for a balanced, medium-term mutual fund portfolio. Learn how to diversify.
Pradeep Gupta of Anand Rathi predicts 2026 will see earnings-led Nifty growth. He advises selectivity in mid & small-caps and highlights domestic cyclicals. Read his full outlook.
Flexi-cap mutual funds attract 28.7% of equity inflows from May-Nov 2025. Experts debate if their flexibility beats multi-cap's discipline for true diversification. Read analysis.
The Bloomberg Dollar Index fell 0.8% this week, its worst since June. Traders await key US jobs and inflation data in January to gauge the Federal Reserve's next interest rate moves. Read more.
Japanese yen weakens against US dollar despite recent BOJ rate hike. Investors watch for potential intervention as Japan proposes record spending. Dollar index rises slightly. #Forex #Yen #Dollar
Despite a surge in retail investors, 2025 proved underwhelming for Indian equities. Discover why large-cap indices like Nifty 50 delivered better returns than mid and small-caps, and how global events shaped the market.